Topic
Non-Muscle Invasive Bladder Cancer (NMIBC)
30 Podcasts • 3 Courses on BackTable
Hear how experienced physicians manage Non-Muscle Invasive Bladder Cancer (NMIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 67 • 18 Jun 2026
Bladder Cancer Risk Stratification: Best Practices
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate and high-risk patients? In this episode of BackTable, Dr. Bogdana Schmidt interviews urologists Dr. Kristen Scarpato and Dr. Sunil Patel to explore the complexities of diagnosis and risk assessment in non–muscle invasive bladder cancer (NMIBC). They discuss the real-world challenges of pathology interpretation, risk-group assignment, evolving diagnostic tools, and the impact these factors have on treatment decisions and patient outcomes.
This podcast is supported by an educational grant from Johnson & Johnson.
More on Non-Muscle Invasive Bladder Cancer (NMIBC)
Loading recent podcasts…
Tumor Board # 67
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
30+ listens
Urology # 308
Jun 11, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
860+ listens
Industry # 101
Jun 9, 2026
with Dr. Ruchika Talwar, Anish Parikh
Are academic medical conferences falling short when it comes to preparing clinicians for the unpredictable realities of...
170+ listens
Urology # 306
Jun 4, 2026
with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...
730+ listens
Urology # 310
Jun 18, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
780+ listens
Tumor Board # 65
Jun 11, 2026
with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam
What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...
100+ listens
Tumor Board # 63
Jun 4, 2026
with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt
Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...
250+ listens
Urology # 305
Jun 2, 2026
with Dr. Sam Chang, Dr. Ruchika Talwar
Ready to move beyond “one-size-fits-all” for BCG-unresponsive NMIBC? In this episode of BackTable Urology, Dr. Ruchika...
1,100+ listens
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.